American Radium Society Scientific Papers and Posters 2016

A Century of Caring Proceedings of the 100th Anniversary Annual Meeting of the American Radium Society - americanradiumsociety.org Scientific Papers (S001) Prognostic Value of Pretreatment Serum Inflammatory Markers in Patients Receiving Radiation Therapy for Oropharyngeal Cancer (S002) A 15-Year Review of Radiation Therapy for Keloids at Two Institutions (S003) Single-Fraction Radiation Therapy for the Treatment of Multiple Myeloma Bony Metastases Provides Pain Control and Decreases Time to Chemotherapy (S004) Trend in Second Malignancy Risk for Head and Neck Cancer With Increased Utilization of IMRT: Analysis of SEER Database (S005) Comparison of Legal Needs of a Group of Patients With Cancer: Economic and Geographic Factors (S006) Mission Improvement: Lessons From Initiating a Resident-Led Quality Improvement Project on Smoking Cessation at a County Hospital (S007) Results of a Phase II Trial Using Cetuximab Plus Docetaxel With Low-Dose Fractionated Radiation for Recurrent Unresectable Locally Advanced Head and Neck Carcinoma (S008) The Effect of Simulation and Treatment Delays for Patients With Oropharyngeal Cancer Receiving Definitive Radiation Therapy in the Era of Risk Stratification Using Smoking and Human Papilloma Virus Status (S009) Intensity-Modulated Radiation Therapy With Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: A Report on Three-Year Toxicity (S010) Computed Tomography–Assessed Measures of Bone Mineral Density and Muscle Mass as Predictors of Survival in Men With Prostate Cancer (S011) Comparative Study Between Ileal Conduit and Indiana Pouch After Cystectomy for Patients With Carcinoma of Urinary Bladder (S012) Quantitative Imaging to Evaluate the Malignant Potential of Pancreatic Cysts (S013) Spine Stereotactic Radiosurgery With Concurrent Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma (S014) The Impact of Radiation Therapy on Survival in Surgically Resected, High-Risk Patients With Ampullary Adenocarcinoma: A Population-Based Analysis (S015) The Impact of Adjuvant Postoperative Radiation Therapy With or Without Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma (S016) The Impact of Stereotactic Body Radiation Therapy on Overall Survival in Patients With Locally Advanced Pancreatic Cancer (S017) A Margin Reduction Study for the Treatment of Gastric Marginal Zone Lymphoma Utilizing a Magnetic Resonance Imaging–Guided Radiation Therapy (MRIgRT) System (S018) Patterns of Care and Survival Outcomes in the Treatment of Esophageal Melanoma (S019) Genomic Homogeneity of Lung and Liver Metastases of a Unique Primary in Individual Patients (S020) The Role of Adjuvant Radiotherapy in T4 Colon Cancer (S021) Success of Prophylactic Single-Fraction Radiation Therapy in the Prevention of Pathologic Femoral Fracture (S022) Gender Differences in Time to Promotion and Scholarly Activity Among Academic Radiation Oncologists (S023) The Radium Chemical Company: 1913–1981 (S024) Axillary Lymph Node Coverage With 3D Tangential Field Irradiation and Correlation With Heart and Lung Dose (S025) Quality of Life Following GammaKnife Radiosurgery for Single and Multiple Brain Metastases (S026) Medical Malpractice in Radiation Oncology (S027) The Emotional Intelligence of Chairs of Academic Radiation Oncology Programs (S028) Is There a Difference in Survival Between Patients With Uterine Papillary Serous, Clear Cell, and Grade 3 Endometrial Cancers? A National Cancer Data Base Analysis (S029) Dosimetric Comparison Between Vaginal Balloons and Rectal Retractors in Intracavitary Brachytherapy (S030) Impact of Adjuvant Radiation Therapy on Overall Survival of Stage I Endometrial Cancer in a Large Hospital-Based Cohort (S031) Prognostic Factors, Treatment, and Outcomes in Early-Stage, Invasive Papillary Breast Cancer (S032) Value of Frequent Follow-Up Mammogram Schedule Following Breast-Conserving Surgery and Radiation Therapy (S033) Local and Locoregional Disease-Free Survival in Patients Receiving NSM or SSM Compared With Conventional Mastectomy (S034) Frequency of Whole-Breast Radiation Therapy Following Intraoperative Radiation Therapy Due to Criteria Identified by Lumpectomy (S035) Validity of Current Stereotactic Body Radiation Therapy (SBRT) Dose Constraints for Aorta and Major Vessels (S036) Increasing Representation of Randomized Controlled Trials Targeting Oligometastatic Disease (S039) Patterns of Care and Outcomes Among Patients Diagnosed With Cutaneous T-Cell Lymphoma (CTCL) (S040) Nadir White Blood Cell, Absolute Neutrophil, and Absolute Lymphocyte Counts During Concurrent Chemoradiation Therapy Predicted Worse Outcomes in Patients With Limited-Stage Small-Cell Lung Cancer (S041) Intensity-Modulated Involved-Site Radiation Therapy for Non-Hodgkin Lymphoma of the Head and Neck (S043) Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? (S045) Specialty Biases Influence Recommended Treatment Strategies for Patients With High-Risk Prostate Cancer: A Patterns-of-Care Study (S046) Prospective Evaluation of Stereotactic Radiation Therapy for Spinal Metastases in the Postoperative Setting: A Secondary Analysis of Mature Phase I/II Trials (S047) Clinical Outcomes Following One or More Courses of Stereotactic Radiosurgery for Brain Metastases From Breast Cancer (S048) Long-Term Survival in Patients With Glioblastoma Multiforme: Frequency and Prognostic Factors (S049) Comparison of Central Nervous System Toxicity Profiles Following Radiosurgery vs Whole-Brain Radiation Among Patients Treated With Immunotherapy (S050) Stereotactic Radiosurgery in the Setting of Immune Checkpoint Blockade Results in Improved Intracranial Control Compared With Whole-Brain Irradiation for Greater Than Three Melanoma Brain Metastases (S051) Disparities in Access and Treatment of Patients With High-Risk Prostate Cancer: Results From a Population-Based Cohort (S052) Pseudoprogression and Radiation Necrosis in Adult Brain Tumor Patients Treated With Proton Beam Radiation Therapy Scientific Posters (P001) Modification of Gene Expression Following Single vs Fractionated Doses of Radiation in Prostate Cancer Cell Lines (P002) HER2 Status and Site of Metastases Predict Survival for Women Treated With Stereotactic Body Radiation Therapy/Stereotactic Radiosurgery (SBRT/SRS) for Oligometastases (P003) Mastectomy vs Breast Conservation for Early-Stage Male Breast Cancer: A Comparison of Oncologic Outcomes (P004) A Comparison of Postmastectomy Radiation Therapy (PMRT) With Protons vs Photons (P005) Excellent Locoregional Control but Modest Overall Survival Achieved in Patients With Inflammatory Breast Cancer (P006) A Retrospective Cohort Analysis of Accelerated Partial Breast Irradiation (APBI) and Whole-Breast Radiation in Patients With Early-Stage Breast Cancer: Toxicities and Clinical Outcomes in a Community Cancer Center (P007) Cardiac and Left Anterior Descending Artery Sparing for Left Whole-Breast Radiation Therapy in the Prone vs Supine Free Breathing and Deep Inspiration Breath-Hold Positioning: A Single-Institution Experience (P008) Prospective Assessment of Simulated Prone Whole-Breast Radiation Therapy vs Supine Whole-Breast Radiation Therapy With Respiratory Gating: Significant Lung Dose Reduction With Prone Positioning (P009) Fractionated Stereotactic Radiation in the Management of Previously Irradiated Brain Metastases (P010) Postoperative Radiation for Primary Melanoma of the Cervical Spinal Cord in a Pregnant Patient: A Case Report (P011) Five-Fraction Stereotactic Body Radiation Therapy (SBRT) for Local Management of Metastatic Pancreatic Cancer (P012) Contralateral Liver Hypertrophy Following Intra-arterial Radioembolization for Liver Tumors (P013) The Role of CA 19-9 in Patients Receiving Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer (P014) Predictors of Long-Term Survival for Localized Prostate Cancer Treated With High-Dose Intensity-Modulated Radiation Therapy (IMRT) Stratified by National Comprehensive Cancer Network (NCCN) 2015 Guidelines in a Community Hospital Setting (P015) Observations in Irradiation of Prostate Cancer (PC) Patients With Existing Prosthetic Penile Implants (P017) Long-Term Biochemical Progression-Free Survival and Quality-of-Life Outcomes in a Single-Institution Cohort of Prostate Cancer Patients Treated by Real-Time Inversely Optimized Prostate Seed Implantation (P018) Low-Dose-Rate, Permanent Prostate Brachytherapy Is an Effective Treatment Option for Men Less Than 55 Years Old With Low-Risk Prostate Cancer (P019) Patterns and Predictors of Local Failure in Cervical Cancer (P020) Adjuvant Chemoradiation Is Associated With Improved Overall Survival in Patients With Stage III Endometrial Cancer: An Analysis of the National Cancer Data Base (P021) Delivery and Outcomes of Adjuvant Radiation Therapy in Older Women With Node-Positive Vulvar Cancer (P022) Effectiveness of Intensity-Modulated Radiation Therapy With Simultaneous Integrated Boost in Cervical Cancer Patients With Positron Emission Tomography (PET)-Positive Lymph Nodes (P023) Role of Concurrent Systemic Therapy With Adjuvant Radiation Therapy for Locally Advanced Cutaneous Squamous Cell Carcinoma (P024) Brainstem and Oral Cavity Sparing in the Adjuvant Treatment of Parotid Cancer: A Comparative Analysis of Volumetric Modulated Arc Therapy (VMAT) and Multifield Optimization Intensity-Modulated Proton Therapy (MFO-IMPT) (P025) Outcomes of Re-irradiation to Epithelial Head and Neck Cancers With Intensity-Modulated Radiation Therapy (P026) The “Decay”Â of Brachytherapy in Tumors of the Oral Cavity: A Population-Based Patterns-of-Care and Outcomes Analysis From 1973 to 2012 (P029) Stereotactic Radiosurgery for Intracranial Metastases of Gynecologic Origin (P030) Efficacy of Stereotactic Radiosurgery (SRS) for Brain Metastases: Is There a Difference in Survival Between First and Second Brain Metastatic Event? (P031) Initial Experience With Combined BRAF and MEK Inhibition With Stereotactic Radiosurgery for BRAF-Mutant Melanoma Brain Metastases (P032) Stereotactic Body Radiation Therapy for Bone Metastases From Prostate Cancer: Techniques and Outcomes From a Large Community Setting (P033) Acute Toxicity and Dose Sparing of Organs at Risk Using SBRT for Orbital Tumors (P035) The Prognostic Value of Pretreatment Peripheral Blood Neutrophil-to-Lymphocyte Ratio in Patients With Soft Tissue Sarcoma (P036) Causes of Mortality Among Cancer Patients (P037) Treatment of Prognostically Favorable Peripheral Nerve Sheath Tumors: A Single-Institution Experience (P038) An MRI-Based Online Adaptive Replanning Tool (P039) Dose-Dependent Change in T2 Relaxation Time Constant in Sarcoma and Normal Tissue (P040) Hyperbaric Oxygen Treatment for Reducing Side Effects of Breast Radiation Therapy (P041) Small Bowel Dose Tolerance in Stereotactic Body Radiation Therapy (SBRT) With Tumor Growth Inhibitors (P042) Development of an Integrated Microfluidic Platform for Automated Proteomic Assay Predictive of Radiation Therapy Outcomes (P043) Postoperative Bolus Electron Conformal Radiation Therapy for Soft Tissue Tumors: Initial Clinical Experience (P044) Comparison of Toxicity-Related Breaks in Treatment Utilizing Intensity-Modulated Radiation Therapy (IMRT) vs Three-Dimensional (3D) Conformal Techniques in the Treatment of Anal Cancer (P045) Esophagus Dose Tolerance for Stereotactic Body Radiation Therapy (SBRT)

American Radium Society Scientific Papers and Posters 2016

A Century of Caring

Scientific Papers

SCIENTIFIC PAPERS

SCIENTIFIC POSTERS

Scientific Posters

Newsletter